Literature DB >> 30401521

CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation.

Athira Unnikrishnan1, Amy M Meacham1, Steven S Goldstein1, Mai Ta1, Helen L Leather1, Christopher R Cogle1, Paul Castillo1, John R Wingard1, Maxim Norkin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30401521     DOI： 10.1016/j.leukres.2018.10.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Authors:  Anne Bouvier; Jérémie Riou; Sylvain Thépot; Aurélien Sutra Del Galy; Sylvie François; Aline Schmidt; Corentin Orvain; Marie-Hélène Estienne; Alban Villate; Damien Luque Paz; Laurane Cottin; Bénédicte Ribourtout; Annaëlle Beucher; Yves Delneste; Norbert Ifrah; Valérie Ugo; Mathilde Hunault-Berger; Odile Blanchet
Journal:  Leukemia       Date:  2019-11-25       Impact factor: 11.528

Review 2.  Chimerism analysis for clinicians: a review of the literature and worldwide practices.

Authors:  Amanda G Blouin; Medhat Askar
Journal:  Bone Marrow Transplant       Date:  2022-01-26       Impact factor: 5.174

Review 3.  Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sophia Chen; Robert Zeiser
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.